Voluntary Disclosure of Sesame as an Allergen: Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request; Extension of Comment Period

Özet

The Food and Drug Administration (FDA or we) is extending the comment period for the draft guidance entitled "Voluntary Disclosure of Sesame as an Allergen: Draft Guidance for Industry," which was announced in the Federal Register of November 12, 2020. We are taking this action in response to requests for an extension to allow interested persons additional time to submit comments.